Caregivers who Knows How to Take Care of Elders

Having elder people who cannot manage to do everything by themselves anymore might get you caught in the middle of two hard choices. Whether you should company them or manage your own things. This is why you can have companion care that will help you to company your old man when you cannot even make a choice. This place will allow you to pay them to company your folks when you cannot do it. They have companion care service which will allow you to take care of your own things without have to worry about your parents anymore. They can help with walking the dogs, do chores in the house, or even become a good talking companion to your folks.

This in home care is not the ones which taken care by young lads who don’t know anything about your story and condition. It’s the one with some seniors who will listen to you well when you need to be listened. With them accompany you as the in home care then you can feel so relaxed now. You won’t make your parents lonely at the house since senior homecare will give them companies and you can still do your business without any problems. This senior homecare will be a nice way out that can manage everything smoothly just as you wish before. By getting the help from them who know your condition and also your parents then it will be much easier than when you just take anyone in. Once you have had this service with you then you can finally let your parents have great time with some people who have known their story and shared the memories from the same time. They will feel relaxed to share stories with people who can understand them. This can be reached with senior’s companion service.

The Insider's Guide To Cancer Prevention

The Guardian online have interviewed some of the leading Cancer specialist to report on how they are preventing cancer through the minefield of misinformation and scientific theories surfacing almost every week. This extract is taken from their website:

These experts spend their lives fighting cancer. They have heard every tip, sensible or not, for how to avoid it. They tell Oliver Laughland how their lifestyles have changed as a result.

The breast specialist

Tena Walters, 51, consultant, London Breast Clinic
Just this week the papers splashed on another piece of research criticising breast cancer screening, saying that for every woman saved by the procedure, up to 10 have been treated unnecessarily. This sort of coverage is a constant annoyance. The evidence just doesn't stack up. I've worked as a breast surgeon for 16 years, and have been having mammograms myself since I was 44, six years younger than the NHS breast cancer screening programme stipulates. To my mind, it is still the strongest preventative measure one can take, and dealing with the disease on a daily basis means I'm lucid with the statistical risks: one in 250 for 40-year-olds, one in 50 for 47-year-olds and, roughly, a one-in-10 lifetime risk.
I nip down to the radiographer once every year, in a spare five minutes, to get it done. It's always on my birthday, so I don't forget. I don't particularly enjoy it, as it can be awkward exposing yourself, especially to people you work with, but you get over it.
Despite coming into contact with the disease on a daily basis, much of my job is about reassuring women they can be successfully treated – I'm often with them through most of their treatment, from diagnosis to chemotherapy and carrying out surgery. Many clinicians working in the field will tell you to do all things in moderation; I abide by this, but also think moderation itself should be done moderately, too. While I lead a generally healthy lifestyle, I drink a glass of wine three nights a week, even though I know it enhances the risk of contracting the disease. I don't live my life in a constant state of paranoia.
One of the most vivid memories I have of my training is caring for an 18-year-old boy dying of leukaemia. There was nothing he should or could have done to stop it. It was then that I was struck by how much of life is a lottery.

The tumour specialist

Kairbaan Hodivala-Dilke, 45, professor of angiogenesis, Queen Mary University, London
It's factor 50 and no less for anyone in my family, and I am obsessive about it. When I see other people's children charging about in the sun without sunblock on, I think they're mad. Even if my two are out for less than an hour, I make sure they're caked in the stuff. My husband is a bluey-skinned, caucasian type – poor him – and absolutely hates wearing it, but when we're visiting family abroad, I can't deal with him unless he's got it slapped on.
At Queen Mary I study how blood vessels grow into cancers. I see the different ways cancer forms and is fed on a daily basis. Of course, I'm viewing it at work, inside a petri dish and through a microscope, but watching it every day makes me acutely aware of any lumps or bumps I see on anyone.
I have known since the age of 14 that I wanted to work in cancer research. My neighbour died of a brain tumour, and seeing the three small children she left behind inspired me to make a change. We're at the stage now, with certain experiments in my lab, where, at a very basic level, we can control cancer growth. There's not really a way to describe how exciting the work can be.
A family friend was recently diagnosed with breast cancer, and is convinced asparagus juice is going to save her. I am unpersuaded. Working as I do in controlled, rigorous research, the constant flow of reports I see presenting new prevention methods, is something I take with a pinch of salt.
The advice I constantly give to friends and family is that if you notice anything untoward, seek expert opinions as quickly as possible.

The neurologist

Peter Rothwell, 47, professor of clinical neurology, University of Oxford and John Radcliffe hospital
I wake early, about 6am, come downstairs, tend to our three young children, then pop my daily low-dose aspirin, doing it on an empty stomach (which isn't recommended, of course), as I don't take breakfast. It has been a routine since my research into the effects of aspirin on cancer prevention really started getting interesting, around three years ago.
We had already shown, in 2007, that taking a high-dose aspirin on a daily basis for about five years reduced the long-term risk of contracting colon cancer by about 50%, but around 2009 we began to show that a low-dose pill had the same effect, as well as significantly reducing the chance of other cancers, including oesophageal.
Most of my research is clinical, but the aspirin work has been mainly paper-based, and over the years I've trawled the archives of many old trials from the 1980s onwards that looked at the effect of a daily aspirin on the risk of stroke and heart attack. We spent hundreds of hours looking through thousands of dusty case notes, extracting information on cancers. It's a lengthy process, and has also required us to trace what happened to participants after the trials finished, to see if they developed cancer subsequently.
Ironically, it has probably not helped my own health, as I conducted the work outside my day job, in spare evenings and weekends, without any funding, and completely stopped exercising because of it.
Having access to the information on people's struggles against cancer has been a great privilege. One of the trials we studied was Sir Richard Doll's British Doctors Trial, where all participants were clinicians themselves, and several were researchers I had admired and revered over the years. It's so important for researchers who advise the public to participate in research or to adopt a particular lifestyle to be willing to do the same themselves. If we don't practise what we preach, we lose a degree of our credibility.

The prostate specialist

Jonathan Waxman, 49, professor of oncology, Imperial College London and Hammersmith hospital
There are established studies that argue vegetarians are 50% less likely to contract certain common cancers than carnivores. Having flirted with vegetarianism at various stages of my life, I eventually gave up 15 years ago – nothing is better than a well-roasted chicken.
I am an oncologist specialising in prostate cancer, and in the early 1980s discovered a pioneering form of medical treatment for the disease, which until then was treated with surgical castration to cut hormone production. It is said a Mediterranean-style diet can be an important preventative tool against cancer of the prostate – eating lots of processed tomato products and olive oil. I do both, predominantly for their taste, and keep a keen eye on my weight.
It is my emotional lifestyle that has changed enormously as a result of working with cancer. Witnessing the effects of such a destructive disease over such a long period has meant locking your emotions away in a freezer, hardly being able to feel any more. I lost my father to cancer, and it was only years later that I came to terms with it. Letting my emotional guard down while discussing it with friends, it finally hit me. Before, I had simply glossed over the pain of my loss.
Cancer is at the forefront of my mind all the time, not simply because of work, but because I fear contracting it. In that respect, it influences my consumption of the things around me. I'm no profligate, so it means appreciating the day, sniffing the air, enjoying the sunshine, treasuring the moment. I love what is around me more as a result of this most deadly disease.

The colorectal specialist

Robert Steele, 60, professor of surgery, Ninewells hospital, University of Dundee
Over the decades spent working in oncology I've made a number of changes to my life. I gave up smoking as a junior doctor while working on a respiratory ward and seeing so many lung cancer patients, I started taking vitamin D tablets after reading research linking a deficiency (of which there is much in Scotland due to the lack of sunlight) to certain types of cancer, and have always watched my weight.
These have all been relatively painless. But in 2007, after attending the launch of the most compelling research I have read into lifestyle choices and cancer, I decided to temper my intake of red meat. As director of the Scottish colorectal cancer screening programme, I was aware of the links between excessive red and cured meat consumption with this and other forms of cancer, yet I still ate one meal a day that contained it.
I'm now down to about twice a week, and have almost completely cut out cured meat. Reneging on bacon rolls has been difficult, but I know that twice a year – new year's day and my birthday – my wife, herself a nutritionist, will cook me them as a treat. It's something to look forward to, at least.
Seeing and operating on colorectal cancers regularly is a powerful stimulus – they don't look pretty at all. But I'm not in the business of telling people certain things should be banned completely. Nor am I one to dismiss leftfield practices outright. As well as surgery and screening, I have research interests in prevention, and have seen projects on all manner of quirky methods. If people wish to use homeopathic medicine in an attempt to prevent cancer, despite there being no medical evidence for its success or any active component whatsoever, the placebo effect itself may be strong.

The lung specialist

Adam Dangoor, 42 medical oncologist, University Hospital Bristol
A while ago I was approached by a teenager outside our local grocery shop. She asked me to buy her some fags, and I had to tell her she'd asked the wrong person. I am a medical oncologist specialising in the treatment of lung cancer; seeing people smoking as young as that is a constant frustration.
Of the lung-cancer patients I deal with, around 90% of them are smokers. Fortunately, I have never taken it up. My mother was a nurse, and when you start your medical training, as a teenager in my case, meeting patients with serious illnesses, it makes you consider your own mortality and think twice about engaging in risky habits.
I recall sharing a flat with smokers a few years back, and was amused at the contradictions in their lifestyles: I'd see one go out and enjoy a heavy night of social smoking and then wake up the next morning and eat a bio-yogurt for the health benefits he thought it would provide. Going out with them could be uncomfortable; before the smoking ban, I'd sit in pubs and sometimes have to leave early as their smoke stung my eyes.
On occasion, I'll have to tell three or four people in a day they've got months to live. It's a difficult part of the job. I try not to take my work home with me or let it affect me too much, but to really empathise with your patients you have to try to see things through their eyes. If I treat someone close to my age with young children, like me, it's hard not to think about it later.
It's not uncommon to have patients approach me, clutching the latest Daily Express front cover, demanding treatment they've seen reported in the tabloids. It can be difficult to explain there's not yet sufficient evidence for offering it – and in some cases no evidence at all.
Ultimately, however, oncology is a hugely satisfying speciality. Whether it be about prolonging life, relieving pain or psychologically supporting a patient and their family through illness, I find what I do hugely rewarding.

Study Links Autism To Maternal Obesity

The following extract has been taken from the NHS Choices website and reports a study published associating the risks for pregnant women (suffering from either obesity or type 2 diabetes) having babies with autism.

“Obese women and those with type 2 diabetes could be increasing their chances of having a child with autism or another development disorder,” BBC News has reported.
The causes of autism and development disorders are not fully understood, and at present researchers are examining a range of environmental and genetic factors that might be involved. This news is based on research examining whether a child's chances of developing these conditions related to their pregnant mother having "metabolic conditions" - diabetes, high blood pressure and obesity. To explore potential links the researchers recruited children with autism spectrum disorder, developmental delay and typical development, and looked at whether their mothers were affected by any of the three metabolic conditions during pregnancy. They found a number of associations between mothers having them and their child's chances of developmental delays and autism, as well as lower scores on several markers of development, particularly expressive language.
Due to its design, the study can only show that metabolic conditions during pregnancy are associated with autism and developmental delays, and can’t prove there is a cause-and-effect relationship. However, the study’s results do warrant more research into the effects of maternal metabolic conditions, perhaps with long-term research that can prove that these conditions actively contribute to autism. Although it will be some time before there is any definite proof, staying a healthy weight during pregnancy remains a sensible measure.

Where did the story come from?

The study was carried out by researchers from the University of California and Vanderbilt University in the US. It was funded by the US National Institutes of Health, the US Environmental Protection Agency and the MIND Institute. The study was published in the peer-reviewed journal Pediatrics.
This story was covered accurately by the BBC and The Daily Telegraph.

What kind of research was this?

This was a case-control study that aimed to investigate associations between mothers’ “metabolic conditions” and the chance of their children having autism or developmental delays during early childhood. In the study the researchers classed diabetes, high blood pressure and obesity (body mass index [BMI] greater or equal to 30) as metabolic conditions, and recorded the prevalence of these conditions in mothers who went on to have children with autism spectrum disorder, developmental delay and typical development. They also aimed to determine whether these metabolic conditions were associated with specific developmental effects.
The researchers state that the prevalence of autism spectrum disorders is 1 in 110 children, making it relatively rare. Case-control studies are a good way to investigate rare events as they look at a group of people with a particular condition and examine their circumstances compared with those of a group of people without the condition. In this way they can look for differences between the two groups that may suggest links to the condition of interest.
Since case-control studies start with people known to have the condition of interest (in this instance, autism) it is possible to enrol a sufficient number of affected patients.Case-control studies also have limitations as they are retrospective, and their control subjects have to be selected carefully in order to minimise the risk of bias. However, it is not always possible to completely remove or minimise bias from the results. Crucially, as they do not follow people up over time they cannot prove cause-and-effect relationships, only find associations.

What did the research involve?

The researchers recruited 1,004 children aged between two and five years: 517 with autism spectrum disorder, 172 with developmental delay and 315 children with typical development. The children with typical development were matched to the children with autism spectrum disorder based on age, gender and the region where they lived.
These typically developing children were identified from state birth records. The diagnoses of autism and developmental delay were confirmed clinically and the children’s development was assessed using two recognised assessments of learning and behaviour: the Mullen Scales of Early Learning (MSEL) and the Vineland Adaptive Behaviour Scale (VABS).
Data on the mothers’ health during the pregnancy was obtained from medical records, birth files and from a structured interview with each mother (the Environmental Exposure Questionnaire). The researchers also collected demographic information on the participants.
The researchers analysed the prevalence of the metabolic conditions in the mothers of children with autism spectrum disorder, developmental delay or children with typical development. They then compared mothers with metabolic conditions with mothers with no metabolic conditions and a BMI of less than 25 (a healthy BMI is between 18 and 25). When the researchers were carrying out the comparisons, they adjusted for a variety of demographic factors including the child’s age and gender, mother’s age at delivery, race/ethnicity, educational level and whether the delivery was paid for by the government or by private medical insurance.

What were the basic results?

The prevalence of type 2 diabetes and gestational diabetes was higher in mothers who went on to have children with autism spectrum disorder or developmental delay. The prevalence was:
  • 9.3% in the autism spectrum disorder group
  • 11.6% in the developmental delay group
  • 6.4% in the control group (typical development)
Having a mother with type 2 diabetes was significantly more common in the children who had developmental delay than in those with typical development (OR 2.33, 95% CI 1.08 to 5.05). For children who had autism spectrum disorder, the rate of maternal diabetes was not significantly different (in other words, it was not meaningful in statistical terms) compared with mothers of children with typical development.
The prevalence of hypertension was low in all groups, but again more common in mothers of children with autism spectrum disorder or developmental delay:
  • 3.7% in the autism spectrum disorder group
  • 3.5% in the developmental delay group
  • 1.3% in the control group
Hypertension was not significantly more common in the developmental delay or autism spectrum disorder groups compared with the control group.
The prevalence of obesity (a BMI of 30 or more) was also more common in mothers of children with autism spectrum disorder or developmental delay:
  • 21.5% in the autism spectrum disorder group
  • 23.8% in the developmental delay group
  • 14.3% in the control group
Compared with the control group, obesity was significantly more common in the developmental delay and autism spectrum disorder groups (OR 2.08 95% CI 1.20 to 3.61 for developmental delay and OR 1.67 95% 1.10 to 2.56 for autism spectrum disorder).
The researchers then considered all three conditions together, which they called “metabolic conditions”. They found that metabolic conditions were more prevalent in mothers of children with autism spectrum disorder and developmental delay compared with mothers of children developing typically. The prevalence of maternal metabolic conditions was:
  • 28.6% in the autism spectrum disorder group
  • 34.9% in the developmental delay group
  • 19.4% in the control group
When compared with the control group these differences were statistically significant for both the mothers of children with autism spectrum disorder (OR 1.61 95% CI 1.10 to 2.37) and developmental delay (OR 2.35 95% CI 1.43 to 3.88).
The researchers then looked at the children’s development, by assessing factors such as their use of language and their motor skills. Maternal diabetes or any metabolic condition was associated with poorer development in the child, particularly expressive language.

How did the researchers interpret the results?

The researchers concluded that maternal metabolic conditions “may be broadly associated with neurodevelopmental problems in children” and that “with obesity rising steadily, these results appear to raise serious public health concerns”.


This case-control study has found an association between maternal metabolic conditions (diabetes, hypertension and obesity) during pregnancy and the chances of children having autism and developmental delays. These conditions were also associated with lower scores on several markers of development, particularly expressive language.
Due to the study design, this study can only show that metabolic conditions are associated with these outcomes. Case-control studies are useful for investigating rare conditions, such as autism spectrum disorder, as case-control studies start with people known to have the outcome, and therefore allow researchers to have sufficient number of patients to study in a meaningful way. However, case-control studies also have limitations. For example:
  • The controls were selected carefully, to minimise the risk of bias, but it is still possible mothers could have been generally healthier for a number of reasons, including  socioeconomic status. This could partially explain the explain the associations seen in the study.
  • Also, the study relied in-part on the mother’s report of her health during pregnancy. This leaves the possibility that there may have been inaccuracy in recording this information, although the researchers did compare a proportion of the results to medical records, and found good agreement.
The exact causes of autism are still not known, but the latest research is looking at the potential genetic and environmental causes of the condition. While this research has provided results suggesting a potential link to maternal metabolic conditions (defined as obesity, diabetes and blood pressure), it should be remembered that the study only found associations rather than a cause-and-effect relationship.
The authors have raised serious public health concerns about rising levels of obesity and the possibility of a link with autism. However, further studies, perhaps of a prospective nature, are needed to continue assessing this potential link. While waiting for definitive proof, staying a healthy weight during pregnancy remains a good idea.